Menu
Recruiting NCT02558699

Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation

No phase Interventional Paroxysmal Atrial Fibrillation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: physician's personal experience, Virtual rotor mapping.
Who it may be relevant to
Registry conditions: Paroxysmal Atrial Fibrillation. Basic parameters: 19 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Radiofrequency catheter ablation is effective in the treatment of patients with paroxysmal atrial fibrillation. In order to reduce the recurrence rate after catheter ablation, the investigators propose to apply 'virtual' ablation on patient-specific atria by simulating 3D atrial computer model. The investigators will conduct virtual rotor mapping in the patient specific atrial model. Then, the investigators will compare the clinical outcome of conventional circumferential pulmonary vein isolation and additional rotor ablation guided by virtual rotor mapping.

Interventions

  • Procedure physician's personal experience
    physician's personal experience
  • Procedure Virtual rotor mapping
    Virtual rotor mapping

Primary outcome measures

  • Recurrence rate of atrial fibrillation of 18 months after procedure within 18 months [Time frame: 18 months]
  • Rate of mortality, incidence of cerebral infarction and hospitalization after procedure [Time frame: 24 months]
Secondary outcome measures (3)
  • Major complication related procedure : Complication of hemorrhagic and embolic [Time frame: 24 months]
  • Pericardial effusion required treatment, 4g/dL reduced level of Hb, Hemorrhage required blood transfusion and Cerebral infarction related procedure [Time frame: 24 months]
  • Procedure time and Radiofrequency ablation time [Time frame: 24 months]

Eligibility criteria

Inclusion criteria

  • AF patient age 19\~80
  • Diagnosis of AF patients who performed catheter ablation of atrial fibrillation due to uncontrolled pulse rate by anti-arrhythmic drug therapy.

Exclusion criteria

  • AF patients who have severe heart deformations or vascular disease.
  • The patient who have renal disease of eGFR<30mL/min
  • The patients who had been performed catheter ablation of atrial ablation and MAZE.
  • The patients who missed out to recording of 3D CT, echo and electrocardiography.
  • the patient have experienced major hemorrhagic complication
  • The patient have experienced ischemic cerebral infarction more 2 times
  • The patient who have risk of ischemic cerebral infarction (CHA2DS2-VASc Score >5)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

South Korea · 1 center
  • Severance Cardiovascular Hospital, Yonsei University Health System — Seoul

Publications

  • Choi Y, Lim B, Yang SY, Yang SH, Kwon OS, Kim D, Kim YG, Park JW, Yu HT, Kim TH, Yang PS, Uhm JS, Shim J, Kim SH, Sung JH, Choi JI, Joung B, Lee MH, Kim YH, Oh YS, Pak HN; CUVIA-REGAB Investigators. Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation Targeting Restitution Parameter-Guided Catheter Ablation: CUVIA-REGAB Prospective Randomized Study. Korean Circ J PMID 35927040

Identifiers

NCT: NCT02558699 · 4-2015-0646

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗